EMBO Molecular Medicine
banner
embomolmed.org
EMBO Molecular Medicine
@embomolmed.org
OpenAccess journal dedicated to high quality research at the interface between clinical & basic science.
Tweets from journal editors
Pinned
New issue online! ➡️ link.springer.com/journal/4432...

The cover highlights the article by S Hirschberger, S Kreth, M Hübner & al 👉 #MitochondrialDamage drives #Tcell immunometabolic paralysis after major surgery: link.springer.com/article/10.1...

Scientific illustration by M Hübner; S Hirschberger
Reposted by EMBO Molecular Medicine
Great to see this team effort out, in which we find a new player in genome stability and a neurodevelopmental disease caused by its loss. Fantastic collaboration with @drjhujh.bsky.social and @profstewartlab.bsky.social alongside @sorenhough.bsky.social and friends in @spjacksongroup.bsky.social.
Loss of CTLH component MAEA impairs #DNArepair and replication and leads to #DevelopmentalDelay

By S. Hough, S. Jackson & colleagues @cam.ac.uk @cruk-ci.bsky.social

🗞️ doi.org/10.1038/s443...
December 19, 2025 at 10:11 PM
Mechanisms of resistance to #VHL loss-induced genetic and pharmacological vulnerabilities ➡️ doi.org/10.1038/s443...

By J. Ge, D. Muñoz-Espín, @svanharanta.bsky.social & colleagues @cam.ac.uk @helsinki.fi
December 19, 2025 at 9:15 PM
Loss of CTLH component MAEA impairs #DNArepair and replication and leads to #DevelopmentalDelay

By S. Hough, S. Jackson & colleagues @cam.ac.uk @cruk-ci.bsky.social

🗞️ doi.org/10.1038/s443...
December 19, 2025 at 9:09 PM
Online today! Mutant #CHCHD10 disrupts cytochrome c oxidation and activates mitochondrial retrograde signaling

by M. Campos-Ribeiro, T. Wai & colleagues @pasteur.fr

👉 doi.org/10.1038/s443...
December 19, 2025 at 9:05 PM
New review by M. Pepin, X. Gong, A. Schulze and J. Backs @uniheidelberg.bsky.social ➡️Metabo-epigenetic circuits of #HeartFailure: chromatin-modifying enzymes as determinants of metabolic plasticity🫀

🗞️ doi.org/10.1038/s443...
December 18, 2025 at 9:23 PM
Clinical relevance of #zebrafish for gene variants testing. Proof-of-principle with SMN1/SMA 👉 doi.org/10.1038/s443...

#SpinalMuscularAtrophy

By B. Stringer, J. Giacomotto and colleagues @griffith.edu.au
December 18, 2025 at 9:16 PM
Reposted by EMBO Molecular Medicine
Microplastics reach human lungs, blood, and brain, yet their biological impact is poorly defined. In our new @embomolmed.org review, we connect environmental exposure to inflammation, stress signalling, epigenetic disruption, and cell identity.
link.springer.com/article/10.1...
Microplastics as environmental modifiers of lung disease - EMBO Molecular Medicine
Human-driven environmental change continues to reshape global patterns of disease, as seen in past pollution-related respiratory crises. Microplastics, persistent synthetic polymer particles, have now...
link.springer.com
December 16, 2025 at 3:14 PM
New Resource Online 👉 Molecular determinants of #CardiacLymphatic dysfunction in a #ChronicPressureOverload model
🗞️ doi.org/10.1038/s443...

by C. Heron, H. Dauchel, @hfpef-diva.bsky.social & colleagues @univrouen.bsky.social @inserm.fr
December 15, 2025 at 9:33 PM
📣 Review on #microplastics as environmental modifiers of #LungDisease 🫁 by E. Epeslidou, @bnmelgert.bsky.social , @stefanprekovic.bsky.social & colleagues @rug.nl & University Medical Center Utrecht

➡️ doi.org/10.1038/s443...
December 15, 2025 at 9:26 PM
Reposted by EMBO Molecular Medicine
New paper out in EMBO Mol Med! We use machine learning to predict Aβ-PET burden from fluid biomarkers. www.embopress.org/doi/full/10....

Key findings:
- Performance R² = 0.79
- CSF Aβ42/Aβ40 most predictive of Aβ plaque presence
- Plasma p-tau217 best for tracking increasing amyloid plaque burden
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid | EMBO Molecular Medicine
imageimageMachine-learning models using CSF and plasma biomarkers accurately predicted quantitative Aβ-PET burden. Distinct contributions of soluble Aβ42/Aβ40 and plasma P-tau217 reveal their role in ...
www.embopress.org
December 2, 2025 at 12:13 PM
Reposted by EMBO Molecular Medicine
One review. Many journals. Less redundancy. Check out this conversation with our head Dr. Thomas Lemberger on the vision behind @reviewcommons.org and what it means for authors and journals alike @embopress.org @embo.org
www.embo.org/people/revie...
Review Commons: rethinking peer review – Features – EMBO
A conversation with Thomas Lemberger, lead of the Review Commons initiative and Head of Open Science Implementation at EMBO.
www.embo.org
December 11, 2025 at 8:52 AM
Loss of #EHMT2 enhances #NKcell -driven #AntiTumorImmunity through #TGFβ1 suppression

by S. Chava, R. Gupta, N. Wajapeyee & colleagues
@uofalabama.bsky.social

doi.org/10.1038/s443...
December 10, 2025 at 4:10 PM
Development of blue light activated, kinetically balanced ChR variants optimized for high-frequency #optogenetic stimulation of SGNs at low light intensities
#cochlearimplants

By L. Roos, T. Moser, T. Mager & colleagues at University Medical Center Göttingen

🗞️ doi.org/10.1038/s44321-025-00350-z
December 10, 2025 at 4:07 PM
Micrometastasis-derived models enable drug testing for early-stage, high-risk #melanoma patients

By K. Weidele, C. A. Klein & colleagues @uniregensburg.bsky.social

➡️ doi.org/10.1038/s44321-025-00339-8
December 10, 2025 at 4:05 PM
New issue online! ➡️ link.springer.com/journal/4432...

The cover highlights the article by S Hirschberger, S Kreth, M Hübner & al 👉 #MitochondrialDamage drives #Tcell immunometabolic paralysis after major surgery: link.springer.com/article/10.1...

Scientific illustration by M Hübner; S Hirschberger
December 10, 2025 at 3:48 PM
Reposted by EMBO Molecular Medicine
Exciting to know that a main finding from our recent publication with @embomolmed.org (link.springer.com/article/10.1...) is taken up in a clinical trial that started a few days ago here in Tübingen and which may revolutionise chemoprophylaxis of malaria: euclinicaltrials.eu/search-for-c....
Complete attenuation of Plasmodium falciparum sporozoites by atovaquone–proguanil - EMBO Molecular Medicine
To develop a Plasmodium falciparum (Pf) vaccine that precludes replication inside the host for improved vaccine safety, we tested chemo-attenuation (CVac) of sporozoites (SPZ) with atovaquone–proguani...
link.springer.com
December 5, 2025 at 4:26 PM
#TyphoidToxin of Salmonella Typhi elicits host antimicrobial response during acute #TyphoidFever

By S. Srour, D. Humphreys & colleagues @sheffielduni.bsky.social

🗞️ doi.org/10.1038/s443...
December 2, 2025 at 8:41 AM
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated #tau and #βamyloid 👉 doi.org/10.1038/s443...

By N. Mattsson-Carlgren, L. Karlsson, O. Hansson & colleagues @lund-university.bsky.social
December 2, 2025 at 8:37 AM
📣This timely review by Chin Lin and colleagues discusses advances in #ArtificialIntelligence -enabled #electrocardiography (AI-ECG) including emerging roles in early disease detection, improved risk stratification, and clinical decision-making.

#TaipeiMedicalUniversity

👉 doi.org/10.1038/s443...
December 2, 2025 at 8:32 AM
Isomeranzin activates Gnas-AMPK signaling to drive white #AdiposeBrowning and curb #obesity in mice ➡️ doi.org/10.1038/s443...

By M. Shi, Y. Ye, L. Hu, L. Yang, K. Huang, M. Liang & colleagues at Huazhong University of Science and Technology
November 27, 2025 at 2:52 PM
Online today! 👉 Dynamics of checkpoint receptors in #γδTcell subsets are associated with clinical response during anti-PD-1 #immunotherapies

By E. Catafal-Tardos, @vasgdtcells.bsky.social & colleagues at Technical University of Denmark

🗞️ doi.org/10.1038/s443...
November 27, 2025 at 2:48 PM
Reposted by EMBO Molecular Medicine
Happy to share our article published in @embomolmed.org in which we demonstrate that the repressor Capicua acts as a natural barrier to lung tumor development driven by Kras/Trp53 mutations. You can read it here: www.embopress.org/doi/full/10....
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations | EMBO Molecular Medicine
imageimageThe inactivation of the repressor Capicua (CIC) promotes the development of lung cancer in Kras/Trp53 mutant mice by transforming bronchiolar Club cells. Loss of CIC in lung cancer cells cau...
www.embopress.org
November 26, 2025 at 10:26 AM
This review by G. Morin, I. Galasso and G. Canaud @inem-necker.bsky.social @upcite.bsky.social presents an overview of the genetic basis of #VascularMalformations (VMs), discussing the ongoing evolution of #PrecisionMedicine for these conditions.

➡️ doi.org/10.1038/s443...
November 24, 2025 at 9:12 PM
Online today! Activated #GlucocorticoidReceptor is an #EstrogenReceptor silencer in ER+ metastatic #BreastCancer

By M. Manivannan, C. Jehanno, @momobentires.bsky.social and colleagues @unibas.ch

👉 doi.org/10.1038/s443...
November 19, 2025 at 8:33 PM
Reposted by EMBO Molecular Medicine
We are pleased to once again partner with @fusionconf.bsky.social for the 2026 conference season! Looking forward to "Fibroblast Growth Factor Signalling in Development, Health & Disease Conference" in March when @embomolmed.org editor Lise Roth will attend.
Registration until 5 Feb: bit.ly/49nSmKj
Fibroblast Growth Factor Signalling in Development, Health & Disease Conference | Fusion Conferences
Receptor Tyrosine Kinases (RTKs) are cell-surface receptors that, upon ligand binding, regulate cell-to-cell communication during embryonic development and in adult life. Among RTKs, the twenty-two Fi...
bit.ly
November 19, 2025 at 10:43 AM